The Telecom Software Giant Shrinks Revenue but Expands Margins While Its Rival Beats Estimates

Photo of William Temple
By William Temple Published

Quick Read

  • Amdocs revenue fell 9% year-over-year to $1.15B but operating income surged 83% to $205.7M.

  • CSG beat Q3 earnings estimates by 17% for its fourth consecutive quarter of positive surprises.

  • Amdocs trades at 11.0x forward P/E with 17.9% operating margin versus CSG at 27.03x P/E with 13.9% operating margin.

  • If you're focused on picking the right stocks and ETFs you may be missing the bigger picture: retirement income. That is exactly what The Definitive Guide to Retirement Income was created to solve, and it's free today. Read more here
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The Telecom Software Giant Shrinks Revenue but Expands Margins While Its Rival Beats Estimates

© Gorodenkoff / Shutterstock.com

Amdocs (NASDAQ: DOX) and CSG Systems (NASDAQ: CSGS) both serve the telecom software market, but their recent earnings show two companies executing very different playbooks. Amdocs posted Q4 2025 results with revenue down 9% year-over-year to $1.15 billion, yet operating income jumped 83% to $205.7 million. CSG reported Q3 2025 revenue of $303.6 million and beat estimates by nearly 17%, marking its fourth consecutive quarter of positive surprises.

One Shrinks Revenue, Expands Margins. The Other Beats Consistently.

Amdocs is playing a margin expansion game. Revenue declined from $1.26 billion in Q4 2024 to $1.15 billion in Q4 2025, but net income climbed from $86.4 million to $97.1 million. Operating margin hit 17.9% for the trailing twelve months. Management is prioritizing profitability over top-line growth, likely by exiting lower-margin contracts and focusing on higher-value digital transformation deals tied to AI and cloud infrastructure.

CSG took a different path. The company delivered $1.31 in Q3 2025 earnings per share against a $1.12 estimate, a 17% beat that followed similar outperformance in Q2 and Q1. Revenue grew 2.9% year-over-year. CSG’s business centers on billing and customer engagement platforms for telecom providers, and the company appears to be capturing share or deepening wallet share with existing clients. Gross margin sits at 46.7%, well above Amdocs’ 37.4%, though operating margin trails at 13.9% versus Amdocs’ 17.9%.

Metric DOX CSGS
Operating Margin (TTM) 17.9% 13.9%
Gross Margin (TTM) 37.4% 46.7%
Recent Earnings Surprise +0.55% (Q4) +16.96% (Q3)
Revenue Growth (YoY) -9% +2.9%

Premium Efficiency vs. Consistent Execution

Amdocs is betting fewer, better deals will drive shareholder value. The forward P/E of 11.0x reflects skepticism about growth, but the 31% jump in operating income suggests the strategy is working. Amdocs serves larger service providers with complex digital transformation needs, which means longer sales cycles but stickier relationships. The 2.55% dividend yield adds a defensive element.

CSG’s approach centers on predictable execution. Four straight quarters of double-digit earnings beats signal strong visibility and conservative guidance. The P/E of 27.03x is higher than Amdocs, reflecting market confidence in earnings quality despite slower revenue growth. CSG’s customer engagement tools are mission-critical for telecom billing, creating recurring revenue but limiting explosive growth potential.

What Matters Next

For Amdocs, the test is whether margin gains can continue if revenue stabilizes or grows. If top-line pressure persists, even strong profitability may not satisfy investors long-term. Watch for commentary on AI-driven product adoption and whether digital transformation budgets from telecom clients accelerate in 2026.

CSG needs to show earnings beats translate into sustained margin expansion. The company has delivered, but gross margin advantage hasn’t fully flowed through to operating income. If CSG can tighten operations while maintaining beat consistency, the valuation premium could expand further.

Why I Prefer DOX for Value, CSGS for Momentum

I lean toward Amdocs if you want a value play with improving profitability and a dividend cushion. The forward P/E of 11.0x looks cheap if the company can stabilize revenue while protecting margins. CSG fits better if you prioritize earnings consistency and don’t mind paying up for execution quality. The 17% Q3 beat shows management credibility, but the 27x P/E leaves less room for error. Neither looks like a home run, but both offer distinct risk-reward profiles depending on whether you value turnaround potential or steady performance.

Photo of William Temple
About the Author William Temple →

I write to invest, and I invest to spend more time with nature. Usually all at the same time. I'm a retired equities guy who saw a recession or four, and lives for what comes out of the other side of them.

I cover stocks across the board cause even though I feel like I've seen it all, there's always another way out there to make, and lose money. I want to help you do more of the former, and none of the latter. Making money with friends is my oxygen.

Let's go!

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SBAC Vol: 6,563,665
INTC Vol: 116,894,024
CCI Vol: 6,078,125
DASH Vol: 5,051,322
GLW Vol: 11,572,082

Top Losing Stocks

ENPH Vol: 6,441,768
TSLA Vol: 82,993,122
GE Vol: 5,322,694
LKQ
LKQ Vol: 4,320,256
SWK Vol: 2,144,540